section name header
Index
Anticholinergic Agents for Chronic Asthma in Adults
Anticholinergic and other Drugs for Overactive Bladder Symptoms in Adults
Anti-Cholinergic Bronchodilators Versus Beta2-Sympathomimetic Agents for Acute Exacerbations of Chronic Obstructive Pulmonary Disease
Anticholinergic Burden (Prognostic Factor) for Prediction of Cognitive Decline in Older Adults with No Known Cognitive Syndrome
Anticholinergic Drugs and Non-Drug Active Therapies for Urgency Urinary Incontinence or Overactive Bladder Syndrome in Adults
Anticholinergics for Maintenance Treatment of Stable COPD
Anti-Cholinergics for Prolonged Cough in Children
Anticholinergic Therapy for Chronic Asthma in Children over Two Years of Age
Evidence summary
Inhaled Bronchodilators for Cystic Fibrosis
Inhaled Ipratropium Bromide Added to Beta2-Agonists for Hospitalized Children with Acute Asthma
Ipratropium as an Adjunct to Beta2 Agonists for Acute Asthma
Ipratropium Bromide Added to Beta2-Agonists in Acute Childhood Asthma
Mirabegron for Urinary Incontinence and Overactive Bladder
Nedocromil and Cromoglycate for Exercise-Induced Bronchoconstriction
Pulmonary diseases
Systematic review